chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Shingles, had the two Shingrix doses/Suspected vaccination failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On 4th September 2022, unknown after receiving Shingrix and Shingrix, the patient experienced shingles. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant). The patient was treated with valaciclovir (Valacyclovir) and gabapentin. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     Additional Information: GSK Receipt Date: 07-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter reported that the on Sunday 04 September 2022 patient was diagnosed with shingles. The patient was prescribed Valacyclovir and gabapentin as treatment. The patient went to pharmacy to get the medications the pharmacist recommended that patient should get the Shingrix vaccine after recovered, patient told him that he already received two doses. Additional supportive information: This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Muscle spasms, Post herpetic neuralgia, Vaccination failure
Clinical narrative: I got the shot, have had the shingles/Suspected vaccination failure; Had the shingles, had every ounce of the systems; Extreme nerve pain; Mussel spasms; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, post herpetic neuralgia and muscle spasm. On an unknown date, the outcome of the vaccination failure, post herpetic neuralgia and muscle spasm were unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, post herpetic neuralgia and muscle spasm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 08-SEP-2022 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient received a dose of Shingles vaccine and since then patient had shingles twice in the last three years. The patient also experienced extreme nerve pain in lower back. The patient stated that both times shingles lasted over 5 months each time. The patient did not got medication as patient's doctor refused to said they were shingles as had no external sores, but had every ounce of the systems. After much research patient was right and doctor was wrong. The patient's doctor kept telling patient they were muscle spasms. Additional Supportive Information: This case was considered as suspected vaccination failure as detail regarding completion of vaccination schedule and laboratory test and time to onset, confirming shingles was unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia, Autoimmune disorder, Neck pain
Clinical narrative: Auto immune response; Joint pain/Pain in shoulders; neck pain; This case was reported by a consumer via interactive digital media and described the occurrence of autoimmune disorder in a 63-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain in extremity (1st dose received for the tolerance of the 1st dose, refer linked case US2022AMR130563).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced autoimmune disorder (serious criteria GSK medically significant), joint pain and neck pain. The patient was treated with steroids nos (Steroid (Not Specified)). On an unknown date, the outcome of the autoimmune disorder, joint pain and neck pain were not recovered/not resolved.   The reporter considered the autoimmune disorder, joint pain and neck pain to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR130563   Additional Information: GSK Receipt Date: 09-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter reported that the patient received second dose of Shingles vaccine. The reporter stated that after received Shingles vaccine the patient experienced pain in every joint in body, pain in neck and pain in shoulder. The reporter stated that it was took several months to determine that the vaccine had give patient an auto immune response. The patient received Steroid as treatment, steroid relieve the pain but as long as patient continue to use. Patient told that this was only happen to one in a million people. The reporter stated that the patient was off the steroid but still had the pain in neck and shoulder. Patient told to everyone that if you had strange symptoms after first dose please does not receive the second dose. Follow-up would not possible as no contact details were available. Additional supportive information: For the tolerance of the 1st dose, refer linked case US2022AMR130563, reported by same reporter.; Sender's Comments:  US-GSK-US2022AMR130563:Same reporter
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: Got shingles after my 2nd jab/Suspected vaccination failure; Shingles; 15 months of pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 09-SEP-2022 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient got shingles after his/her 2nd Shingles vaccine in the same arm. Patient had pain for 15 months. Additional supportive information: This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Extra dose administered, Herpes zoster, Vaccination failure
Clinical narrative: Had three shots, still got shingles/Suspected vaccination failure; Shingles; Had three shots; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 3rd dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and extra dose administered. On an unknown date, the outcome of the vaccination failure, shingles and extra dose administered were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 10-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter reported that the patient received three doses of Shingles vaccine. The reporter stated that after received three doses of Shingles vaccine patient experienced with Shingles. Follow-up would not possible as no contact details were available. Additional supportive information: This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The patient received 3rd dose of Shingles vaccine, which led to extra dose administrated.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: got the vaccine, now has shingles/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 10-SEP-2022 Reporter's Comments: This case was received from patient's friend via interactive digital media. The reporter reported that when they first brought out the shingles vaccine the reporter decided not to get it. The reporter best friend (patient) got the shingles vaccine. It had been several years, and she now had shingles and the reporter did not had shingles. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Can one get SHINGLES ,after the vaccine/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 11-Sept-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient asked that could one get shingles, after receiving the shingles vaccine. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure, Varicella
Clinical narrative: Still got them/ Suspected vaccination failure; Still got them; chiken pox; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and chickenpox. On an unknown date, the outcome of the vaccination failure, shingles and chickenpox were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and chickenpox to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 11-SEP-2022 Reporter's Comments: This case was received from patient via interactive digital media. The patient had the Chicken pox, the vaccine and still got them. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. As it was unclear if the patient experienced chickenpox before or after the Shingles vaccine, hence conservatively captured as event.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Took the vaccine and got shingles/Suspected vaccination failure; Got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-SEP-2022 Reporter's Comments: This case was received from patient via interactive digital media. The patient reported that under the recommendation of his/her doctor the patient took the vaccine. The patient got the shingles a year later. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Have shingles now/Suspected vaccination failure; Have shingles now; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient had the Shingles shot and had shingles now but no pain. The patient reported that had to pay years ago for the shot well worth it due to the fact that the patient had shingles now no pain. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: COVID19, FLUX, MMR, TYP, UNK, VARZOS, YF
Symptoms: Headache, Pain in extremity, Pyrexia
Clinical narrative: Standard symptoms of a sore arm; Occasionally a headache; Mild fever; This case was reported by a consumer via other manufacturer and described the occurrence of pain in arm in a 59-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu unspecified (Influenza vaccine) for prophylaxis, MMR (MMR vaccine) for prophylaxis, COVID-19 VACCINE for prophylaxis, DIPHTHERIA VACCINE TOXOID, TETANUS VACCINE TOXOID (DT (DIPHTHERIA AND TETANUS TOXOIDS VACCINE)) for prophylaxis, TYPHOID VACCINE (TYPHOID) for prophylaxis and YELLOW FEVER VACCINE (YELLOW FEVER) for prophylaxis.   On an unknown date, the patient received Shingrix, Influenza vaccine, MMR vaccine, COVID-19 VACCINE, DT (DIPHTHERIA AND TETANUS TOXOIDS VACCINE), TYPHOID and YELLOW FEVER. On an unknown date, unknown after receiving Shingrix, Influenza vaccine and MMR vaccine, the patient experienced pain in arm, headache and fever. On an unknown date, the outcome of the pain in arm, headache and fever were unknown.   It was unknown if the reporter considered the pain in arm, headache and fever to be related to Shingrix, Influenza vaccine and MMR vaccine.     Linked case(s) involving the same patient: US2022AMR121345   Additional Information: GSK receipt date- 18-Aug-2022 and 24-Aug-2022 Reporter's comment: The patient never had a serious reaction to any vaccine (e.g. influenza, Covid-19, MMR, DT, typhoid, Shingrix and yellow fever). The patient experienced except the standard symptoms of a sore arm and occasionally a headache or a mild fever. The lot number was not provided. Any other additional information was not provided (sample size, etc.). On an unknown date, unknown after receiving Covid-19 Vaccine, DT (Diphtheria and Tetanus toxoids vaccine, Typhoid and yellow fever, the patient experienced pain in arm, headache and fever.  It was unknown if the reporter considered the pain in arm, headache and fever to be related to Covid-19 Vaccine, DT (Diphtheria and Tetanus toxoids vaccine, Typhoid and yellow fever.    The reporter did not consent to follow up.; Sender's Comments:  US-GSK-US2022AMR121345:Same reporter.
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Chills, Fatigue, Feeling hot, Herpes zoster
Clinical narrative: fever over 100 degrees; chills; body aches; fatigue; Shingles appear on the arm; itched; warm; blistered, leaked clear fluid; This case was reported by a consumer and described the occurrence of fever in a 55-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chickenpox (had a light case of chicken pox as a infant) and shingles (patient had a shingles at  the age of 15 years old for 1 week).   On 1st September 2022, the patient received the 2nd dose of Shingrix. In September 2022, 12 hrs after receiving Shingrix, the patient experienced fever, chills, general body pain, fatigue, shingles, pruritus, feeling of warmth and blister. On an unknown date, the outcome of the fever, chills, general body pain, fatigue, shingles, pruritus, feeling of warmth and blister were unknown.   It was unknown if the reporter considered the fever, chills, general body pain, fatigue, shingles, pruritus, feeling of warmth and blister to be related to Shingrix.     Additional Information: GSK Receipt Date: 3-Sep-2022 Reporter's Comment:  The patient had a light case of chicken pox as a infant and then a week long bout with shingles at 15 years old. The patient received the 2nd Shingrix vaccination and had several side effects starting 12 hours later including a fever over 100 degrees, chills, body aches, fatigue, but also had what looks like two Shingles appear on the arm opposite the one that received the shot. The itched, were warm, blistered and leaked clear fluid with in 48 hours of the shot. Less than a weeks after vaccination, the patient experienced pruritus, feeling of warmth and blister. This needs to be reported as a possible side effect.
Sex: M
Vaccine: VARZOS
Symptoms: Pain, Pruritus, Pyrexia
Clinical narrative: fever over 100 degrees; chills; body aches; fatigue; Shingles appear on the arm; itched; warm; blistered, leaked clear fluid; This case was reported by a consumer and described the occurrence of fever in a 55-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chickenpox (had a light case of chicken pox as a infant) and shingles (patient had a shingles at  the age of 15 years old for 1 week).   On 1st September 2022, the patient received the 2nd dose of Shingrix. In September 2022, 12 hrs after receiving Shingrix, the patient experienced fever, chills, general body pain, fatigue, shingles, pruritus, feeling of warmth and blister. On an unknown date, the outcome of the fever, chills, general body pain, fatigue, shingles, pruritus, feeling of warmth and blister were unknown.   It was unknown if the reporter considered the fever, chills, general body pain, fatigue, shingles, pruritus, feeling of warmth and blister to be related to Shingrix.     Additional Information: GSK Receipt Date: 3-Sep-2022 Reporter's Comment:  The patient had a light case of chicken pox as a infant and then a week long bout with shingles at 15 years old. The patient received the 2nd Shingrix vaccination and had several side effects starting 12 hours later including a fever over 100 degrees, chills, body aches, fatigue, but also had what looks like two Shingles appear on the arm opposite the one that received the shot. The itched, were warm, blistered and leaked clear fluid with in 48 hours of the shot. Less than a weeks after vaccination, the patient experienced pruritus, feeling of warmth and blister. This needs to be reported as a possible side effect.
Sex: U
Vaccine: VARZOS
Symptoms: Infection, Neck pain
Clinical narrative: extreme neck pain associated with the infection; associated with the infection; This case was reported by a consumer via interactive digital media and described the occurrence of neck pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced neck pain and infection. On an unknown date, the outcome of the neck pain and infection were unknown.   It was unknown if the reporter considered the neck pain and infection to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 04-SEP-2022 Reporter's Comments: This case was received from consumer via interactive digital media. The patient took his/her first dose of the shingles injection.  The reporter wanted to know was it normal to had very extreme neck pain associated with the infection. The follow-up could not be possible as no contact details were available.